News
-
-
-
-
-
-
PRESS RELEASE
OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM
OSE Immunotherapeutics reaffirms strategic priorities with comprehensive Q&A document ahead of AGM. Company focuses on Tedopi® and Lusvertikimab programs for value creation -
PRESS RELEASE
Inside Information / Other news releases
-
PRESS RELEASE
EQS-Adhoc: REPLOID Group AG: BAERLOCHER becomes a shareholder in REPLOID and develops a strategic partnership for the upcycling of biogenic waste streams for use in biopolymers.
REPLOID Group AG and BAERLOCHER form strategic partnership for biogenic waste upcycling to create biopolymers -
PRESS RELEASE
Edisun Power Europe AG: Challenging half-year results underscore the need for the new ‘Renewables to AI’ strategy
Edisun Power Europe AG reports challenging half-year results with revenue decline and net loss, emphasizing the new 'Renewables to AI' strategy. Lower solar power production and cost factors affected financial performance -
